Fuente: PubMed "Cannabis" Med J Malaysia. 2026 Mar;81(2):259-266.ABSTRACTINTRODUCTION: Currently, several countries have implemented regulations governing the use of medical cannabis. Recreational use of cannabis is illegal under Malaysian laws and it is unclear what medical practitioners think of cannabis when it is used for medical purposes. We conducted a nationwide survey in Malaysia to study the attitudes, beliefs and willingness of public medical practitioners to prescribe medical cannabis.MATERIALS & METHODS: A 23-item online questionnaire was administered to 420 medical practitioners working in government institutions. Participant demographics, clinical specialities, employment history, exposure to knowledge of medical cannabis and case vignettes related to the use of medical cannabis were collected and analysed.RESULTS: Sixty-five percent of medical practitioners agreed that medical cannabis should be available for certain conditions, particularly pain (87%). Most medical practitioners in the case vignettes were willing to recommend medical cannabis to treat pain due to cancer (74.3%) and chronic pain (66.9%). Logistic regression indicated that both gender and exposure to information on medical cannabis are significant factors (p<0.05) in predicting the willingness of medical practitioners to prescribe medical cannabis.CONCLUSION: Medical practitioners in the public institutions showed favourable attitudes towards prescribing medical cannabis for chronic pain and cancer pain. However, further work is required to examine factors that drive these attitudes, and potential prescribing behaviour including those in private and university settings. A thorough evaluation of the scientific evidence and related legislation is essential, especially if a regulated pathway is to be adopted. In this situation, medical practitioners must have a clear understanding of clinical practice guidelines regarding pain indications, dosing and monitoring protocols as well as effective pharmacovigilance. Additionally, this should be combined with targeted evidence-based training on medical cannabis for medical practitioners.PMID:41914585